These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33603772)

  • 1. Prevalence of the Brazilian
    Vieira IA; Andreis TF; Fernandes BV; Achatz MI; Macedo GS; Schramek D; Ashton-Prolla P
    Front Genet; 2021; 12():606537. PubMed ID: 33603772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIR605 rs2043556 is associated with the occurrence of multiple primary tumors in TP53 p.(Arg337His) mutation carriers.
    Bandeira IC; Vieira IA; Andreis TF; Brussa Reis L; Macedo GS; Vianna FSL; Santos-Silva P; Palmero EI; Galvão HCR; Ramos CRN; Santiago KM; Achatz MI; da Costa AABA; Ashton-Prolla P
    Cancer Genet; 2020 Jan; 240():54-58. PubMed ID: 31778928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical and Molecular Profile of Lung Cancer Patients Harboring the
    Lopes CDH; Antonacio FF; Moraes PMG; Asprino PF; Galante PAF; Jardim DL; de Macedo MP; Sandoval RL; Katz A; de Castro G; Achatz MI
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
    Hahn EC; Bittar CM; Vianna FSL; Netto CBO; Biazús JV; Cericatto R; Cavalheiro JA; de Melo MP; Menke CH; Rabin E; Leistner-Segal S; Ashton-Prolla P
    PLoS One; 2018; 13(12):e0209934. PubMed ID: 30596752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p.
    Paskulin DD; Giacomazzi J; Achatz MI; Costa S; Reis RM; Hainaut P; dos Santos SE; Ashton-Prolla P
    PLoS One; 2015; 10(11):e0143262. PubMed ID: 26618902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Phenotype Associated With Li-Fraumeni Syndrome: A Brazilian Cohort Enriched by
    Sandoval RL; Polidorio N; Leite ACR; Cartaxo M; Pisani JP; Quirino CV; Cezana L; Pereira NG; Pereira AAL; Rossi BM; Achatz MI
    Front Oncol; 2022; 12():836937. PubMed ID: 35371985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brazilian founder mutation TP53 p.R337H is uncommon in Portuguese women diagnosed with breast cancer.
    Giacomazzi J; Correia RL; Palmero EI; Gaspar JF; Almeida M; Portela C; Camey SA; Monteiro A; Pinheiro M; Peixoto A; Teixeira MR; Reis RM; Ashton-Prolla P
    Breast J; 2014; 20(5):534-6. PubMed ID: 25052705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni Syndrome.
    Formiga MNDC; de Andrade KC; Kowalski LP; Achatz MI
    JAMA Oncol; 2017 Oct; 3(10):1400-1402. PubMed ID: 28114597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome.
    Macaulay S; Goodyear QC; Kruger M; Chen W; Essop F; Krause A
    Fam Cancer; 2018 Oct; 17(4):607-613. PubMed ID: 29392648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service.
    Matta BP; Gomes R; Mattos D; Olicio R; Nascimento CM; Ferreira GM; Brant AC; Boroni M; Furtado C; Lima V; Moreira MÂM; Dos Santos ACE
    Sci Rep; 2022 Nov; 12(1):18629. PubMed ID: 36329109
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    da Silva PFF; Goveia RM; Teixeira TB; Gamba BF; de Lima AP; Rogatto SR; Silveira-Lacerda EP
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625568
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation.
    Andrade KC; Santiago KM; Fortes FP; Mambelli LI; Nóbrega AF; Achatz MI
    Genet Mol Biol; 2016 May; 39(2):199-202. PubMed ID: 27223487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence.
    Seidinger AL; Caminha IP; Mastellaro MJ; Gabetta CS; Nowill AE; Pinheiro VRP; Yunes JA
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1168. PubMed ID: 32592449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas.
    Vieira IA; Viola GD; Pezzi EH; Kowalski TW; Fernandes BV; Andreis TF; Bom N; Sonnenstrahl G; Rocha YMA; Corrêa BDS; Donatti LM; Sant'Anna GDS; Corleta HVE; Brum IS; Rosset C; Vianna FSL; Macedo GS; Palmero EI; Ashton-Prolla P
    Genet Mol Biol; 2024; 46(3 Suppl 1):e20230133. PubMed ID: 38252059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.
    Cury NM; Ferraz VE; Silva WA
    Hered Cancer Clin Pract; 2014 Mar; 12(1):8. PubMed ID: 24625245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
    Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
    Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child: evidence for chimerism involving a common mutant founder haplotype: case report.
    da Silva EM; Achatz MI; Martel-Planche G; Montagnini AL; Olivier M; Prolla PA; Hainaut P; Soares FA
    BMC Cancer; 2011 Oct; 11():449. PubMed ID: 22004116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.